ArticlemBio2022
Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018).
Open access · goldAbstract read
In one paragraph
Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
7.9field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 88 citations in OpenAlex.
- Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list.Medical mycology · 2024Pooled it
- Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens.Medical mycology · 2024Pooled it
- Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.Medical mycology · 2023Pooled it
- Immunological fitness of echinocandin-resistantVirulence · 2026Article
- Invasive Wickerhamomyces anomalus Infections among Injecting Drug Users, France, 2012-2024Emerging infectious diseases · 2026Article
- Pediatric yeast fungaemia species patterns, resistance profiles, and outcomes: a 20-year surveillance study in Paris, France.EClinicalMedicine · 2026Article
- Whole genome sequencing analysis of Candida glabrata isolates collected from patients with selected drug-resistant candidiasis hospitalized in Eastern Poland.Folia microbiologica · 2026Article
- Clinical characteristics and risk factors for mortality in pulmonary mucormycosis among patients with non-hematologic malignancies.BMC pulmonary medicine · 2026Article
- Evaluation of the ELITe InGenius PCR assay compared with immunofluorescence for Pneumocystis jirovecii detection in respiratory samples.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Pathogen-specific epidemiology and clinical trajectories of fungal infections after kidney transplantation: a prospective multicenter cohort study.BMC infectious diseases · 2026Article
- A step toward defining optimal liposomal amphotericin B treatment duration in pulmonary mucormycosis: results from emulated trials.Antimicrobial agents and chemotherapy · 2026Article
- EmergentMicroorganisms · 2026Review
- Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026Review
- Clinical Manifestations of Emerging Trichosporon spp. Infections, France.Emerging infectious diseases · 2026Article
- Antifungal Resistance Surveillance: Insights From National Mycology Reference Centers and Expert Mycology Laboratories.Open forum infectious diseases · 2026Article
- Burden of Invasive Fungal Diseases in Patients With Alcohol-Related Hepatitis and Organ Failure.Alimentary pharmacology & therapeutics · 2026Article
- Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential.Virulence · 2025Article
- Clinical characteristics ofJournal of thoracic disease · 2025Article
- The 2025 EQUALJAC-antimicrobial resistance · 2025Article
- Association of peripheral-blood neutrophil-to-lymphocyte ratio withJournal of thoracic disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 20 institutions in 4 countries.
Stéphane BretagneInstitut Pasteurgrid.428999.7, Université Paris Cité, CNRS, Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, UMR 2000, Paris, France.
Karine SitbonInstitut Pasteurgrid.428999.7, Université Paris Cité, CNRS, Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, UMR 2000, Paris, France.
Marie Desnos-Ollivier *Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS, Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, UMR 2000, Paris, France.ORCID 0000-0002-9137-0466
Dea Garcia-Hermoso *Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS, Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, UMR 2000, Paris, France.
Valérie Letscher-BruLaboratory of Parasitology and Medical Mycology, Strasbourg University Hospital, Institute of Parasitology and Tropical Diseases, UR7292 Dynamics of Host-Pathogen Interactions, Federation of Translational Medicine, University of Strasbourg, Strasbourg, France.
Sophie CassaingSophie Cassaing: Department of Parasitology and Mycology, CHU Toulouse, Restore Institute, Toulouse, France.
Laurence MillonLaboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Besançon, UMR 6249 CNRS Chrono-Environnement, University Bourgogne Franche-Comté, Besançon, France.
Florent MorioNantes Université, CHU Nantes, Cibles et Médicaments des Infections et du Cancer, IICiMed, UR 1155, Nantes, France.
Jean-Pierre GangneuxUniv Rennes, CHU, INSERM, Irset: Institut de Recherche en Santé, Environnement et Travail, UMR_S 1085, Rennes, France.
Lilia HasseineLaboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Nice, Nice, France.
Loïc FavennecEA 7510, Centre Hospitalier UC. Nicolle, Rouen, France.
Estelle CateauLaboratoire de Mycologie, CHU de Poitiers, UMR CNRS 7267, Poitiers, France.
Eric BaillyLaboratoire de Parasitologie-Mycologie-Médecine Tropicale, CHRU Tours, France.
Maxime MoniotService de Parasitologie-Mycologie, CHU Clermont-Ferrand, 3iHP, Clermont-Ferrand, France.
Julie BonhommeDepartment of Microbiology, University Hospital of Caen, ToxEMAC-ABTE, Unicaen Normandie University, Caen, France.
Nicole Desbois-NogardLaboratoire de Parasitologie-Mycologie, CHU de la Martinique, Fort de France, France.
Taieb ChouakiMycologie-Parasitologie, CHU d'Amiens, Amiens, France.
André PaugamLaboratoire de Mycologie, Hôpital Cochin, Paris, France.
Bernard BouteilleDepartment of Parasitology and Mycology, University Hospital, Limoges, France.
Marc PihetLaboratoire de Parasitologie-Mycologie, CHU d'Angers, University Angers, University Brest, GEIHP, SFR ICAT, Angers, France.
Frédéric DalleUniversity Bourgogne Franche-Comté, Agrosup Dijon, UMR PAM A 02.102, Dijon, France.
Odile EloyCentre Hospitalier de Versaillesgrid.418080.5, Le Chesnay, France.
Milène SassoLaboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Nîmesgrid.411165.6, Université de Montpellier, CNRS, IRD, UMR MiVEGEC, Montpellier, France.ORCID 0000-0002-6539-8545
Magalie DemarLaboratoire Hospitalo-Universitaire de Parasito-Mycologie, centre hospitalier de Cayenne Guyane, Cayenne, France.
Patricia Mariani-KurkdjianCHU Robert Debré, Paris, France.
Vincent RobertBioinformatics Group, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Olivier LortholaryInstitut Pasteurgrid.428999.7, Université Paris Cité, CNRS, Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, UMR 2000, Paris, France.
Françoise DromerInstitut Pasteurgrid.428999.7, Université Paris Cité, CNRS, Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, UMR 2000, Paris, France.ORCID 0000-0003-1671-1475
French Mycoses Study Group
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRAgents infectieux, résistance et chimiothérapie · FRCentre Hospitalier Universitaire de Tours · FRCentre Hospitalier Universitaire Amiens-Picardie · FRBiodiversity Research Institute · USCentre Hospitalier de Versailles · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Martinique · MQCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Rouen · FRCibles et Médicaments des Infections et de l'ImmunitéHôpital Cochin · FRHôpital Necker-Enfants Malades · FRHôpital Robert-Debré · FRHôpital Universitaire Dupuytren · FRInserm · FRInstitut Agro Dijon · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
The French National Reference Center for Invasive Mycoses and Antifungals leads an active and sustained nationwide surveillance program on probable and proven invasive fungal diseases (IFDs) to determine their epidemiology in France. Between 2012 and 2018, a total of 10,886 IFDs were recorded. The incidence increased slightly over time (2.16 to 2.36/10,000 hospitalization days,
Indexed as
AspergillosisFungemiaInvasive Fungal InfectionsMucormycosisPneumonia, PneumocystisAgedAntifungal AgentsHumansWatchful WaitingAntifungal Agentsaspergillosiscandidemiaepidemiologyinvasive fungal infectionsmucormycosispneumocytosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.